Skip to main content
PMC home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 2003;11(4):209–216. doi: 10.1080/10647440300025523

Improving Appropriate Use of Antifungal Medications: The Role of an Over-the-Counter Vaginal pH Self-Test Device

Subir Roy 1,✉, James C Caillouette 2, Joel S Faden 3, Tapon Roy 4, Diana E Ramos 5
PMCID: PMC1852289  PMID: 15108867

Abstract

Objectives: To determine whether patients can understand and use the vaginal pH device in the diagnosis of vaginitis. To compare whether vaginal pH readings determined by patients and healthcare providers are similar. To determine whether vaginalpHcan reduce inappropriate over-the-counter (OTC) antifungal medication use and improve the correct diagnosis of vaginitis.

Methods: One hundred and fifty-one women indicated their belief about the cause of their vaginal infection, read the instructions of the vaginal pH device package insert, used the device and interpreted the findings. The patient interpretations were compared with results obtained by healthcare providers, blinded to patient findings.

Results: Over 96% of patients stated that they could easily read the instructions, use the vaginal pH device and interpret the readings. They obtained the same readings as healthcare professionals (Kappa = 0.9). Restricting the use of OTC antifungal medications to those individuals with vaginitis symptoms and vaginal pH ≤ 4.5 significantly reduced inappropriate use by approximately 50%, Fisher's exact test,p-value = 0.018. Conversely, seeking healthcare provider assessment with vaginal pH > 4.5, leads to correct diagnosis of vaginitis.

Conclusions: The vaginal pH device can be used as an OTC diagnostic tool by consumers when a vaginal infection is suspected. Vaginal pH readings would direct patients whether to purchase an antifungal medication or seek professional diagnosis from a healthcare provider. Understanding and use of this vaginal pH device could reduce inappropriate use of OTC antifungal medications by approximately 50% and improve the correct diagnosis of vaginitis.

Full Text

The Full Text of this article is available as a PDF (455.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amsel R., Totten P. A., Spiegel C. A., Chen K. C., Eschenbach D., Holmes K. K. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med. 1983 Jan;74(1):14–22. doi: 10.1016/0002-9343(83)91112-9. [DOI] [PubMed] [Google Scholar]
  2. Boskey E. R., Telsch K. M., Whaley K. J., Moench T. R., Cone R. A. Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect Immun. 1999 Oct;67(10):5170–5175. doi: 10.1128/iai.67.10.5170-5175.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Caillouette J. C., Sharp C. F., Jr, Zimmerman G. J., Roy S. Vaginal pH as a marker for bacterial pathogens and menopausal status. Am J Obstet Gynecol. 1997 Jun;176(6):1270–1277. doi: 10.1016/s0002-9378(97)70345-4. [DOI] [PubMed] [Google Scholar]
  4. Cohen C. R., Duerr A., Pruithithada N., Rugpao S., Hillier S., Garcia P., Nelson K. Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS. 1995 Sep;9(9):1093–1097. doi: 10.1097/00002030-199509000-00017. [DOI] [PubMed] [Google Scholar]
  5. Eschenbach D. A., Hillier S., Critchlow C., Stevens C., DeRouen T., Holmes K. K. Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol. 1988 Apr;158(4):819–828. doi: 10.1016/0002-9378(88)90078-6. [DOI] [PubMed] [Google Scholar]
  6. Ferris Daron G., Nyirjesy Paul, Sobel Jack D., Soper David, Pavletic Adriana, Litaker Mark S. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol. 2002 Mar;99(3):419–425. doi: 10.1016/s0029-7844(01)01759-8. [DOI] [PubMed] [Google Scholar]
  7. Gregoire A. T., Kandil O., Ledger W. J. The glycogen content of human vaginal epithelial tissue. Fertil Steril. 1971 Jan;22(1):64–68. doi: 10.1016/s0015-0282(16)37989-4. [DOI] [PubMed] [Google Scholar]
  8. Hillier S. L., Nugent R. P., Eschenbach D. A., Krohn M. A., Gibbs R. S., Martin D. H., Cotch M. F., Edelman R., Pastorek J. G., 2nd, Rao A. V. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med. 1995 Dec 28;333(26):1737–1742. doi: 10.1056/NEJM199512283332604. [DOI] [PubMed] [Google Scholar]
  9. LANG W. R. Vaginal acidity and pH; a review. Obstet Gynecol Surv. 1955 Aug;10(4):546–560. doi: 10.1097/00006254-195508000-00009. [DOI] [PubMed] [Google Scholar]
  10. Platz-Christensen J. J., Sundström E., Larsson P. G. Bacterial vaginosis and cervical intraepithelial neoplasia. Acta Obstet Gynecol Scand. 1994 Aug;73(7):586–588. doi: 10.3109/00016349409006278. [DOI] [PubMed] [Google Scholar]
  11. Ross R. A., Lee M. L., Onderdonk A. B. Effect of Candida albicans infection and clotrimazole treatment on vaginal microflora in vitro. Obstet Gynecol. 1995 Dec;86(6):925–930. doi: 10.1016/0029-7844(95)00318-l. [DOI] [PubMed] [Google Scholar]
  12. Sihvo S., Ahonen R., Mikander H., Hemminki E. Self-medication with vaginal antifungal drugs: physicians' experiences and women's utilization patterns. Fam Pract. 2000 Apr;17(2):145–149. doi: 10.1093/fampra/17.2.145. [DOI] [PubMed] [Google Scholar]
  13. Sweet R. L. Role of bacterial vaginosis in pelvic inflammatory disease. Clin Infect Dis. 1995 Jun;20 (Suppl 2):S271–S275. doi: 10.1093/clinids/20.supplement_2.s271. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES